Therapeutic potential of a novel IP-10-(anti-HER2 scFv) fusion protein for the treatment of HER2-positive breast cancer

被引：0
作者：
Maryam Ahmadzadeh
Elham Mohit
机构：
[1] Shahid Beheshti University of Medical Sciences,Department of Pharmaceutical Biotechnology, School of Pharmacy
[2] The Ministry of Health and Medical Education,Food and Drug Administration
来源：
Biotechnology Letters | 2023年 / 45卷
关键词：
Breast cancer; HER2; scFv; Chemokine; IP-10; Trastuzumab;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：371 / 385
页数：14
相关论文
共 311 条
  • [81] Struyf S(undefined)undefined undefined undefined undefined-undefined
  • [82] Buracchi C(undefined)undefined undefined undefined undefined-undefined
  • [83] Vecchi A(undefined)undefined undefined undefined undefined-undefined
  • [84] Kinscherf R(undefined)undefined undefined undefined undefined-undefined
  • [85] Kiessling F(undefined)undefined undefined undefined undefined-undefined
  • [86] Paschek S(undefined)undefined undefined undefined undefined-undefined
  • [87] Sozzani S(undefined)undefined undefined undefined undefined-undefined
  • [88] Rommelaere J(undefined)undefined undefined undefined undefined-undefined
  • [89] Guo J-Q(undefined)undefined undefined undefined undefined-undefined
  • [90] Chen L(undefined)undefined undefined undefined undefined-undefined
45678910111213